Caroline E. Fife, M.D., Latisha Smith, M.D., Jaime Aristizabal, M.D., Karen Parker, R.N.

Dr. Fife has done research supported by NASA, Organogenesis, Inc, Bedfont Scientific Ltd., National Headache Foundation, BristolMyersSquibb, R.W. Johnson Pharmaceuticals and Ciba. Dr. Smith has done research supported by Parke Davis/Warner Lambert, Chrysalis, Inc. and Organogenesis, Inc, and has given lectures supported by Ortho-McNeil.

Dr. Aristizabal and Ms. Parker reports no commercial conflict of interest.

This activity is made possible by an unrestricted educational grant from the Novartis Foundation for Gerontology.

Release Date: 12/08/1999
Termination Date: 12/08/2002

Estimated time to complete: 1 hour(s).

Albert Einstein College of Medicine designates this enduring material for a maximum of 0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Albert Einstein College of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Upon completion of this Cyberounds^®, the participant should be able to:

• Identify the clinical indications for using semi-synthetic human skin in a non-healing wound
• Describe the proposed mechanism of action of semi-synthetic human skin in effecting wound closure
• Discuss the basic issues relating to chronic wound management.

 

This conference may include discussion of commercial products and services.

The opinions expressed herein are those of the authors and do not necessarily represent the views of the sponsor or its publisher. Please review complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacologic therapy to patients.

 

Please click below to accept the terms of this CME activity